The DREAM Study

The DREAM trial was presented in Copenhagen over the last weekend in the results are quite exciting for all of those with diabetes of any kind. The word DREAM means Diabetes REduction Assessment… with Medication. The research indicated that the use of Rosiglitazone (Avandia) at the dose of 8 mg daily for 3 years decreased the incidence of diabetes almost by two-thirds.

Eastern individuals in high-risk categories. This study identify the risk status increased weight and a strong family history of diabetes.

Those who would detract from the study point out that diet and exercise have been proven to retard diabetes onset even though it is very difficult for some individuals to keep up that diabetes prevention program.

The study is published in the Lancet, the British medical journal available online to you if you wish to read the study in its entirety.